G
D. T. Khong, Z. M. A. Judeh
Paper
Synthesis
HRMS (ESI+): m/z [M + H]+ calcd for C14H21NO: 220.1701; found:
13C NMR: δ = 30.6, 36.6, 56.0, 59.9, 65.1, 70.2, 111.5, 117.1, 122.4,
220.1701.
125.6, 127.4, 127.8, 128.0, 128.3, 128.4, 134.5, 137.6, 145.8.
HRMS (ESI+): m/z [M + H]+ calcd for C18H20N2O: 281.1654; found:
281.1659.
[(1R,3S)-1-Isopropyl-2-methyl-1,2,3,4-tetrahydroisoquinolin-3-
yl]methanol (7f)
The crude product from N-methylation of THIQ 7f was purified by
column chromatography (hexane/EtOAc, 1:3) to give THIQ 7f as a yel-
low oil; yield: 177 mg (81%); [α]D22 –14 (c 1.0, MeOH).
N-Methylation of THIQ and C2-BIQ Using MeI; General Procedure
A solution of the respective THIQ or C2-BIQ (1 mmol) in MeI (4 mL)
was stirred for 12 h at r.t. The mixture was then evaporated under re-
duced pressure to give a dark gum. CH2Cl2 (5 mL) and 5 M aq NaOH
solution (5 mL) were added to the gum. The resulting biphasic mix-
ture was stirred for 1 h, and then the layers were separated. The aque-
ous phase extracted with CH2Cl2 (3 × 10 mL) and the combined organ-
ic phases were washed with brine, dried (MgSO4), filtered, and evapo-
rated under reduced pressure. The crude product obtained was
purified by column chromatography. The procedure was used to syn-
thesize the following compounds:
FTIR (KBr): 2967, 1457, 1241, 1033 cm–1
.
1H NMR: δ = 1.03 (d, J = 6.6 Hz, 3 H), 1.11 (d, J = 6.6 Hz, 3 H), 1.92–2.04
(m, 1 H), 2.15 (s, 3 H), 2.52 (d, J = 8.4 Hz, 2 H), 3.13 (d, J = 9.3 Hz, 1 H),
3.48 (quint, J = 7.5 Hz, 1 H), 3.62 (dd, J = 2.1, 9.5 Hz, 2 H), 7.09–7.20
(m, 4 H).
13C NMR: δ = 20.7, 21.3, 24.9, 32.0, 34.6, 52.7, 62.2, 70.7, 125.2, 126.2,
129.0, 129.8, 133.5, 136.5.
HRMS (ESI+): m/z [M + H]+ calcd for C14H21NO: 220.1701; found:
220.1698.
[(1S,3S)-1-{2-(Dimethylamino)phenyl]-2-methyl-1,2,3,4-tetrahy-
droisoquinolin-3-yl}methanol (7c)
[(1R,3S)-1-tert-Butyl-2-methyl-1,2,3,4-tetrahydroisoquinolin-3-
yl]methanol (7g)
The crude product was purified by column chromatography (hex-
ane/EtOAc, 1:1) to give compound 7c as a white solid; yield: 200 mg
(67%); mp 155–156 °C; [α]D22 –88 (c 1.0, MeOH).
FTIR (KBr): 2939, 1488, 1454, 1102, 947, 744 cm–1
1H NMR: δ = 2.41 (s, 3 H), 2.75 (d, J = 6.9 Hz, 2 H), 2.85 (s, 6 H), 3.48–
3.70 (m, 3 H), 5.59 (s, 1 H), 6.70 (d, J = 7.2 Hz, 1 H), 6.83–6.94 (m, 2 H),
7.06–7.10 (m, 1 H), 7.11–7.23 (m, 4 H).
The crude product from N-methylation of THIQ 7g was purified by
column chromatography (hexane/EtOAc, 1:3) to give THIQ 7g as a yel-
low solid; yield: 205 mg (88%); mp 67 °C; [α]D22 –3 (c 1.0, MeOH).
.
FTIR (KBr): 2978, 2887, 1091, 1041, 756 cm–1
.
1H NMR: δ = 1.03 (s, 9 H), 2.18 (s, 3 H), 2.51 (d, J = 7.5 Hz, 2 H), 3.39 (s,
1 H), 3.56–3.68 (m, 3 H), 7.07–7.26 (m, 4 H).
13C NMR: δ = 24.5, 29.8, 35.0, 36.6, 52.6, 62.5, 73.2, 125.3, 126.3,
13C NMR: δ = 25.5, 35.1, 45.9, 53.2, 61.3, 61.4, 120.6, 123.5, 126.3,
128.0, 128.9, 129.6, 131.2, 133.7.
129.1, 129.8, 133.8, 135.6.
HRMS (ESI+): m/z [M + H]+ calcd for C15H23NO: 234.1858; found:
HRMS (ESI+): m/z [M + H]+ calcd for C19H24N2O: 297.1967; found:
297.1973.
234.1858.
Bis[(1S,3S)-3-(hydroxymethyl)-6,7-dimethoxy-2-methyl-1,2,3,4-
tetrahydroisoquinolin-1-yl]methane (10b)
[(1R,3S)-1-Cyclohexyl-2-methyl-1,2,3,4-tetrahydroisoquinolin-3-
yl]methanol (7h)
The crude product was purified by column chromatography
(CH2Cl2/MeOH, 95:5) to give 10b as a white foam; yield: 286 mg
(59%); mp 144 °C; [α]D22 –19 (c 1.0, MeOH).
The crude product from N-methylation of THIQ 7h was purified by
column chromatography (hexane/EtOAc, 1:3) to give THIQ 7h as a yel-
low oil; yield: 233 mg (90%); [α]D22 –49.5 (c 1.0, MeOH).
FTIR (KBr): 2936, 2857, 1759, 1453, 1037, 754 cm–1
1H NMR: δ = 1.05–1.18 (m, 6 H), 1.46–1.67 (m, 5 H), 2.05 (s, 3 H), 2.44
(d, J = 8.1 Hz, 2 H), 2.82 (br s, 1 H), 3.13 (d, J = 9 Hz, 1 H), 3.38 (quint,
J = 8.0 Hz, 1 H), 3.51 (d, J = 3.3 Hz, 1 H), 3.53 (d, J = 0.9 Hz, 1 H), 6.97–
7.11 (m, 4 H).
13C NMR: δ = 24.8, 26.44, 26.49, 26.51, 30.8, 31.5, 34.5, 41.4, 52.4,
62.3, 69.7, 125.0, 126.3, 129.1, 130.0, 133.5, 136.2.
HRMS (ESI+): m/z [M + H]+ calcd for C17H25NO: 260.2014; found:
FTIR (KBr): 2940, 1514, 1467, 1350, 1242, 1119, 1029 cm–1
.
.
1H NMR: δ = 2.12 (t, J = 7.5 Hz, 2 H), 2.32 (s, 6 H), 2.40–2.61 (m, 4 H),
3.36–3.42 (m, 2 H), 3.57–3.73 (m, 4 H), 3.89 (s, 6 H), 3.90 (s, 6 H), 3.98
(t, J = 7.8 Hz, 2 H), 6.54 (s, 2 H), 6.58 (s, 2 H).
13C NMR: δ = .23.9, 34.1, 38.8, 50.06, 50.49, 55.9, 61.9, 109.9, 111.7,
124.9, 129.3, 147.63, 147.68.
HRMS (ESI+): m/z [M + H]+ calcd for C27H38N2O6: 487.2808; found:
487.2816.
260.2018.
(1R,3R)-3-(Hydroxymethyl)-1-{3-[(1R,3R)-3-(hydroxymethyl)-2-
methyl-1,2,3,4-tetrahydroisoquinolin-1-yl]phenyl}-2-methyl-
1,2,3,4-tetrahydroisoquinoline (10c)
[(8S,13bS)-5-Methyl-6,8,9,13b-tetrahydro-5H-isoquinolino[2,1-
c]quinazolin-8-yl]methanol (8)
The crude product was purified by column chromatography
(CH2Cl2/MeOH, 95: 5) to give 10c as a white foam; yield: 270 mg
(63%); [α]D22 –140 (c 1.0, MeOH),
The crude product from N-methylation of THIQ 8 was purified by col-
umn chromatography (hexane/EtOAc, 1: 1) to give THIQ 8 as a white
solid; yield: 270 mg (96%); mp 179 °C; [α]D22 +260 (c 1.0, CH2Cl2).
FTIR (KBr): 1605, 1328, 1219, 1087, 1016, 742 cm–1
1H NMR: δ = 1.65 (br s, 1 H), 2.67–2.84 (m, 2 H), 2.88 (s, 3 H), 3.23–
3.28 (m, 1 H), 3.46 (dd, J = 6.3, 9 Hz, 1 H), 3.68 (dd, J = 6.3, 9 Hz, 1 H),
4.03 (d, J = 10.8 Hz, 1 H), 4.3 (d, J = 10.8 Hz, 1 H), 5.23 (s, 1 H), 6.61 (dt,
J = 0.9, 7.5 Hz, 1 H), 6.68 (d, J = 8.4 Hz, 1 H), 6.76 (d, J = 7.5 Hz, 1 H),
7.10–7.25 (m, 5 H).
FTIR (KBr): 2943, 1738, 1654, 1454, 1243, 1042, 748 cm–1
.
.
1H NMR: δ = 2.38 (s, 6 H), 2.41–2.73 (m, 4 H), 3.13 (quint, J = 3.8 Hz, 2
H), 3.46–3.62 (m, 4 H), 4.87 (s, 2 H), 6.87 (dd, J = 7.65, 1.5 Hz, 2 H),
7.16 (d, J = 7.2 Hz, 2 H), 7.09–7.25 (m, 8 H).
13C NMR: δ = 25.8, 35.6, 52.9, 61.7, 67.9, 126.0, 126.8, 127.6, 128.2,
129.2, 129.6, 130.1, 133.8, 134.6, 142.8.
© Georg Thieme Verlag Stuttgart · New York — Synthesis 2016, 48, A–I